Flash Finance

Rainbow Childrens Medicare LimitedRAINBOWCorporate

Healthcare Medical Care Facilities Latest results: Jun 2026 15 quarters of data
Consolidated Standalone
₹1,248.90
MCap ₹12,670 Cr · P/E 43.7
Rainbow Childrens Medicare Limited — Stock analysis & AI research Rainbow Childrens Medicare Limited — Multibagger AI analysis Rainbow Childrens Medicare Limited — Seasonality — best & worst months Rainbow Childrens Medicare Limited — Technical indicators & charts Rainbow Childrens Medicare Limited — Technical setup — score, trend, support & resistance Rainbow Childrens Medicare Limited — Live exchange announcements
📋 High Operating Margin Stocks 📈 Lowest Technical Score📈 Multi-Timeframe Bearish Stocks 🏭 Healthcare sector
AI-assisted data: figures and text on this page are extracted from public quarterly filings with AI assistance, checked automatically and overseen by our editorial team (human in the loop). They may still contain errors or omissions. Verify critical numbers against official company / SEBI / NSE / BSE filings before making any decision. Educational information only, not financial advice.
₹470 Cr
Sales · Jun 2026
+33.2% YoY
₹135 Cr
Operating Profit · Jun 2026
+29.9% YoY
28.6%
OPM % · Jun 2026
-2.7% YoY
₹63 Cr
Net Profit · Jun 2026
+16.2% YoY
₹5.97
EPS · Jun 2026
+13.3% YoY

📝 Rainbow Childrens Medicare Limited — results explained

Quarter ended June 2026 (Q1 FY27)

Rainbow Childrens Medicare Limited reported revenue of ₹470 crore for the quarter ended June 2026 (Q1 FY27), up 33.2% from ₹353 crore in the same quarter last year, and up 2.2% sequentially over the March 2026 quarter.

Net profit rose 16.2% year-on-year to ₹63 crore, from ₹54 crore. Earnings per share (EPS) came in at ₹5.97.

Operating profit stood at ₹135 crore — an operating margin (OPM) of 28.6%, compared with 29.4% in the year-ago quarter.

Full year and trailing twelve months

For the full year FY26, Rainbow Childrens Medicare Limited posted revenue of ₹1,703 crore, a growth of 12.4% over FY25, with a net profit of ₹281 crore (up 15.2% year-on-year).

On a trailing-twelve-month (TTM) basis, revenue stands at ₹1,820 crore with a net profit of ₹290 crore.

Valuation snapshot

At the current price of ₹1,248.90, RAINBOW has a market capitalisation of ₹12,670 crore and a trailing P/E of about 43.7.

Within the Medical Care Facilities industry, it is the 9th-largest of the 11 companies we track by market value.

Shareholding pattern

As of Sep 2026, promoters held 49.83%, foreign institutional investors (FIIs) 14.66%, domestic institutional investors (DIIs) 23.28%, public shareholders 11.83% of Rainbow Childrens Medicare Limited.

📈 Share price & events

📊 Quarterly trend

₹ crore · OPM % on right axis

🎯 Key metrics

price-linked ratios use the latest close
Valuation
Market Cap ?
₹12,670 Cr
Current Price ?
₹1,248.9
P/E ?
43.68below ind
Industry P/E ?
56.40
P/B ?
7.68
P/S ?
6.96
P/FCF ?
62.11
Enterprise Value ?
₹13,561 Cr
EV/EBITDA ?
23.56
PEG ?
4.37
Earnings Yield ?
3.1%
Dividend Yield ?
0.28%
Profitability & Returns
Sales (TTM) ?
₹1,820 Cr
OPM ?
31.6%
Profit after tax (TTM) ?
₹290 Cr
EPS (TTM) ?
₹28.59
ROCE ?
18.0%
ROE ?
17.6%
ROA ?
10.5%
Growth
Sales — latest qtr ?
₹470 Cr
PAT — latest qtr ?
₹63 Cr
YoY qtr sales growth ?
33.2%
YoY qtr profit growth ?
16.2%
Sales growth (3y) ?
13%
Sales growth (5y) ?
21%
Profit growth (3y) ?
10%
Profit growth (5y) ?
48%
Financial Health
Debt ?
₹891 Cr
Debt to Equity ?
0.54
Interest Coverage ?
5.1
Current Ratio ?
N/A
Ownership
Promoter holding ?
49.83%
Change in promoter holding ?
-0.02%
Pledged percentage ?
N/A
Market
Return 3 months ?
-16.4%
Return 6 months ?
0.0%

🗓️ Quarterly results (15 quarters · ₹ Cr)

same fiscal quarter as Jun bestweakest per row · for costs (interest, NPAs) low is best
Metric Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026 YoY % QoQ %
Sales 306317287333336341330417398370353445445460470 +33.2% +2.2%
Operating Profit 107988811811810694147134115104149147145135 +29.9% -7.1%
Other Income 89889131211131520811413 -36.5% +217.8%
Interest 141415131417181818181819202021 +17.3% +6.0%
Depreciation 232325272832343535343436404142 +23.4% +2.9%
Profit Before Tax 78705685856953105947771102988784 +17.6% -3.5%
Net Profit 585441636351407969575476747863 +16.2% -19.8%
EPS 5.745.284.046.206.125.023.897.776.765.555.277.417.147.595.97 +13.3% -21.3%
OPM % 34.8% 30.9% 30.5% 35.3% 35.1% 30.9% 28.4% 35.2% 33.8% 31.0% 29.4% 33.5% 33.0% 31.5% 28.6% -2.7% -9.2%

📆 Annual results (₹ Cr, FY = Apr–Mar)

Metric FY25 FY26 TTM YoY %
Sales ₹1,516 Cr ₹1,703 Cr ₹1,820 Cr +12.4%
Operating Profit ₹490 Cr ₹544 Cr ₹575 Cr +11.1%
OPM % 32.32% 31.97% 31.62% -1.1%
NPM % 16.11% 16.52% 15.94% +2.5%
Other Income ₹51 Cr ₹43 Cr ₹35 Cr -16.2%
Depreciation ₹138 Cr ₹151 Cr ₹159 Cr +8.8%
Interest ₹72 Cr ₹77 Cr ₹80 Cr +6.4%
EBIT ₹351 Cr ₹394 Cr ₹417 Cr +12.1%
PBT ₹330 Cr ₹358 Cr ₹371 Cr +8.6%
Tax ₹86 Cr ₹68 Cr ₹72 Cr -20.6%
Net Profit ₹244 Cr ₹281 Cr ₹290 Cr +15.2%
EPS ₹23.97 ₹27.41 ₹28.11 +14.4%
Material Cost ₹195 Cr ₹170 Cr ₹187 Cr -12.8%
Employee Cost ₹206 Cr ₹170 Cr ₹186 Cr -17.4%
Extraordinary Items — — — —

🏛️ Balance Sheet (latest 4 periods)

Metric Mar 2023Mar 2024Mar 2025Mar 2026 % Chg
Equity Capital 102102102102 +0.0%
Reserves 9581,1571,3671,547 +13.2%
Borrowings 570765764891 +16.6%
Other Liabilities 146146145236 +62.8%
Total Liabilities 1,7762,1702,3772,775 +16.7%
Fixed Assets 9311,2531,3981,759 +25.8%
CWIP 23202876 +171.4%
Investments 58308571404 -29.2%
Other Assets 764590380535 +40.8%
Total Assets 1,7762,1702,3772,775 +16.7%

💧 Cash Flow (latest 4 periods)

Metric Mar 2023Mar 2024Mar 2025Mar 2026 % Chg
Cash from Operating Activity 327321396420 +6.1%
Cash from Investing Activity -465-226-268-259 +3.4%
Cash from Financing Activity 143-102-118-147 -24.6%
Net Cash Flow 5-71014 +40.0%
Free Cash Flow 186-32250204 -18.4%
CFO/OP 102%95%97%96% -1.0%

➗ Ratios (latest 4 periods)

Metric Mar 2023Mar 2024Mar 2025Mar 2026 % Chg
Debtor Days 18201922 +15.8%
Inventory Days 43535267 +28.8%
Days Payable 195180170162 -4.7%
Cash Conversion Cycle -133-107-100-73 +27.0%
Working Capital Days 73441995 +400.0%
ROCE % 24%19%19%18% -5.3%

👥 Shareholding (latest 5 periods)

Metric Jun 2025Sep 2025Dec 2025Mar 2026Sep 2026 % Chg
Promoters 49.85%49.85%49.84%49.84%49.83% -0.0%
FIIs 23.60%21.85%19.24%17.24%14.66% -15.0%
DIIs 15.44%17.46%19.49%21.12%23.28% +10.2%
Public 11.11%10.82%11.40%11.68%11.83% +1.3%
Others 0.00%0.00%0.04%0.12%— —
No. of Shareholders 80,32081,13488,80988,56192,814 +4.8%

⚖️ Peer comparison

Industry: Medical Care Facilities · 11 companies · full page →
# Company CMP MCap (Cr) P/E Sales TTM NP TTM OPM% NPM% Sales YoY% NP YoY% Qtr Rev Δ% Qtr NP Δ%
1 APOLLOHOSP Apollo Hospitals ₹7,988.50 114,862 59.2 25,229 2,002 14.9% 7.9% 15.8% 33.1% 18.1% 32.9%
2 MAXHEALTH Max Healthcare ₹1,037.70 101,000 69.2 8,712 1,457 26.6% 16.7% 19.1% 34.1% 16.7% 4.9%
3 MANIPALHOS Manipal Health ₹710.85 93,504 — — — — — — — 28.2% -8.3%
4 FORTIS Fortis Healthcare ₹887.80 67,025 64.3 9,128 1,064 22.8% 11.7% 17.3% 31.4% 17.8% 44.1%
5 ASTERDM Aster DM ₹763.50 66,552 198.5 4,876 363 19.0% 7.5% 44.2% 138.8% 21.6% -68.9%
6 MEDANTA Global Health ₹1,445.60 38,846 69.8 4,683 553 20.9% 11.8% 19.4% 15.1% 26.5% -1.1%
7 NH Narayana Hrudayalaya ₹1,869.90 37,978 46.6 9,073 817 19.3% 9.0% 41.4% 1.9% 78.0% 5.4%
8 KIMS Krishna Institute ₹767.50 30,711 148.9 4,214 194 19.8% 4.6% 28.7% -41.5% 35.3% -56.0%
9 RAINBOW Rainbow Children's ₹1,450.00 14,710 51.6 1,820 290 31.6% 15.9% 12.4% 15.2% 33.2% 16.2%
10 GAUDIUMIVF Gaudium IVF ₹116.42 847 36.4 106 23 32.9% 21.8% — — 9.1% -42.2%
11 MOMSBELIEF Rays of Belief ₹223.00 466 — — — — — — — 136.4% 616.1%
❓ Frequently asked questions
What was Rainbow Childrens Medicare Limited's revenue in Q1 FY27?
Rainbow Childrens Medicare Limited reported revenue of ₹470 crore for the quarter ended June 2026 (Q1 FY27), up 33.2% from ₹353 crore in the same quarter last year, and up 2.2% sequentially over the March 2026 quarter.
What was Rainbow Childrens Medicare Limited's net profit in Q1 FY27?
Net profit rose 16.2% year-on-year to ₹63 crore, from ₹54 crore. Earnings per share (EPS) came in at ₹5.97.
What is RAINBOW's market capitalisation and P/E ratio?
At the current price of ₹1,248.90, RAINBOW has a market capitalisation of ₹12,670 crore and a trailing P/E of about 43.7.
Who owns Rainbow Childrens Medicare Limited? (shareholding pattern)
As of Sep 2026, promoters held 49.83%, foreign institutional investors (FIIs) 14.66%, domestic institutional investors (DIIs) 23.28%, public shareholders 11.83% of Rainbow Childrens Medicare Limited.
TTM ends 2026-06-30. Amounts are ₹ crore unless stated otherwise. Figures are extracted by AI from public quarterly filings; gaps are filled from public market data. Live price refreshed about twice a day from exchange data. Educational information only — not financial advice.
⚠️ How this site is made: Market data pages are computed automatically from NSE/BSE publications and company filings; news articles and announcement analyses are written with AI assistance, with a human in the loop: our editors review what the AI produces. Both can contain errors. Verify with the original sources before any investment decision. Not investment advice; Flash Finance is not SEBI-registered. How we use AI